机译:EBI-2511的发现:一种高效和口服活性的EZH2抑制剂,用于治疗非霍奇金淋巴瘤
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Etern Biosci Inc 6 Cedarbrook Dr Cranbury NJ 08512 USA;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Etern Biosci Inc 6 Cedarbrook Dr Cranbury NJ 08512 USA;
Etern Biosci Inc 6 Cedarbrook Dr Cranbury NJ 08512 USA;
Etern Biosci Inc 6 Cedarbrook Dr Cranbury NJ 08512 USA;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Etern Biosci Inc 6 Cedarbrook Dr Cranbury NJ 08512 USA;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Shanghai Hengrui Pharmaceut Co Ltd 279 Wenjing Rd Shanghai 200245 Peoples R China;
Benzofuran; EZH2; lymphoma; scaffold hopping;
机译:EBI-2511的发现:一种高效和口服活性的EZH2抑制剂,用于治疗非霍奇金淋巴瘤
机译:EBI-907的发现:一种高效和口服活性的B-RAF(V600E)抑制剂,用于治疗黑素瘤和相关癌症
机译:EBI-907的发现:一种高效,口服活性的B-Raf(V600E)抑制剂,用于治疗黑素瘤和相关癌症
机译:天然犬淋巴瘤诊断和治疗单结构域抗体的发展:人非霍奇金淋巴瘤的动物模型
机译:针对非霍奇金淋巴瘤的新型治疗策略,以翻译机制为目标。
机译:EBI-2511的发现:高效口服活性EZH2抑制剂治疗非霍奇金淋巴瘤
机译:EBI-2511的发现:一种高效且口服活性的EZH2抑制剂,用于治疗非霍奇金淋巴瘤